Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer.

作者: Niels Reinmuth , Sebastian Kloos , Arne Warth , Angela Risch , Thomas Muley

DOI: 10.1016/J.HUMPATH.2014.01.010

关键词:

摘要: Summary The purpose of this study was to characterize the prevalence insulin-like growth factor 1 receptor ( IGF1R ) mutations, single nucleotide polymorphisms (SNP), and protein overexpression in surgically resected non–small cell lung cancers relation patient characteristics prognosis. This retrospective conducted on 304 patients with who underwent curative pulmonary resection (median follow-up for surviving patients, 3.6 years). gene alterations (n = 304) expression 181) were evaluated by polymerase chain reaction–based assays immunohistochemistry, respectively. Membranous cytoplasmic staining analyzed separately. In an exploratory analysis, silent mutation exon 16 3 mutations introns comprising tyrosine kinase domain detected. Moreover, evaluating selected SNPs, adenocarcinomas homozygous rs8038415 T-allele had a significantly better survival P .025) but no different disease-free survival. Regarding expression, membranous not higher squamous carcinomas versus other histologies .08). No association between SNP variations found. is does correlate SNPs can be detected may harbor prognostic value. These interest when as potential therapeutic target should receive further research.

参考文章(27)
James W. Mandell, Phosphorylation State-Specific Antibodies : Applications in Investigative and Diagnostic Pathology American Journal of Pathology. ,vol. 163, pp. 1687- 1698 ,(2003) , 10.1016/S0002-9440(10)63525-0
Daniele Campa, Phillip Müller, Lutz Edler, Lena Knoefel, Roberto Barale, Claus P. Heussel, Michael Thomas, Federico Canzian, Angela Risch, A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis International Journal of Cancer. ,vol. 131, pp. 2920- 2928 ,(2012) , 10.1002/IJC.27567
Tatyana Kalinina, Maximilian Bockhorn, Jussuf T. Kaifi, Sabrina Thieltges, Cenap Güngör, Katharina E. Effenberger, Andrea Strelow, Uta Reichelt, Guido Sauter, Klaus Pantel, Jakob R. Izbicki, Emre F. Yekebas, Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus. International Journal of Cancer. ,vol. 127, pp. 1931- 1940 ,(2010) , 10.1002/IJC.25196
Gregor Fürstenberger, Hans-Jörg Senn, Insulin-like growth factors and cancer. Lancet Oncology. ,vol. 3, pp. 298- 302 ,(2002) , 10.1016/S1470-2045(02)00731-3
Todd M. Pitts, Aik Choon Tan, Gillian N. Kulikowski, John J. Tentler, Amy M. Brown, Sara A. Flanigan, Stephen Leong, Christopher D. Coldren, Fred R. Hirsch, Marileila Varella-Garcia, Christopher Korch, S. Gail Eckhardt, Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development Clinical Cancer Research. ,vol. 16, pp. 3193- 3204 ,(2010) , 10.1158/1078-0432.CCR-09-3191
Kimberley Macdonald, Geoffrey A. Porter, Duane L. Guernsey, Ronghua Zhao, Alan G. Casson, A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. Cancer Epidemiology. ,vol. 33, pp. 37- 40 ,(2009) , 10.1016/J.CANEP.2009.04.014
David Sidransky, Emerging molecular markers of cancer Nature Reviews Cancer. ,vol. 2, pp. 210- 219 ,(2002) , 10.1038/NRC755
D B Scherf, N Sarkisyan, H Jacobsson, R Claus, J L Bermejo, B Peil, L Gu, T Muley, M Meister, H Dienemann, C Plass, A Risch, Epigenetic screen identifies genotype- specific promoter DNA methylation and oncogenic potential of CHRNB4 Oncogene. ,vol. 32, pp. 3329- 3338 ,(2013) , 10.1038/ONC.2012.344
Ronghua Zhao, Kimberley Macdonald, Alan G. Casson, Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma. Molecular Carcinogenesis. ,vol. 48, pp. 982- 988 ,(2009) , 10.1002/MC.20562